Clinic
Medcare Express LLC
Medcare Express LLC was paid $7.49M by Medicaid between Jan 2018 and Dec 2024, across 39 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoMEDCARE EXPRESS LLC
NEWINGTON, CT 06111
NEWINGTON, CT 06111
33aNPI1316124548assigned 01/30/2008
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.49M
24GClaims129,157
24DCodes billed39
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Connecticut
Rank by total paid#3 of 21
Median peer was paid$606K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,610 | $869K | |
| 2019 | 12,703 | $805K | |
| 2020 | 15,204 | $920K | |
| 2021 | 28,333 | $1.63M | |
| 2022 | 22,902 | $1.23M | |
| 2023 | 19,107 | $1.07M | |
| 2024incomplete | 16,298 | $972K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 33,332 | 26,619 | $2.90M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 26,487 | 21,707 | $1.66M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14% | 21,872 | 18,381 | $1.01M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 9,424 | 8,362 | $864K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.2% | 4,669 | 4,285 | $318K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 5,824 | 4,710 | $235K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 6,598 | 5,474 | $120K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 802 | 746 | $95K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 810 | 757 | $90K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,679 | 5,222 | $60K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 241 | 232 | $27K |
| 99384 | <1% | 137 | 125 | $17K |
27 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,233 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 916 | $11K |
| 99173 | <1% | 1,623 | $11K | |
| 90686 | <1% | 789 | $9K | |
| 93000 | <1% | 687 | $8K | |
| 99383 | <1% | 51 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 54 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 28 | $4K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 108 | $4K |
| 99385 | <1% | 26 | $4K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 44 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 869 | $3K |
| 69210 | <1% | 85 | $2K | |
| 86580 | <1% | 329 | $2K | |
| 90662 | <1% | 79 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 113 | $1K |
| 81025 | <1% | 157 | $857.68 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 44 | $738.15 |
| 90715 | <1% | 42 | $613.98 | |
| G0008 | Administration of influenza virus vaccine | <1% | 107 | $470.26 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 69 | $273.92 |
| 81002 | <1% | 4,439 | $216.60 | |
| 90694 | <1% | 18 | $142.20 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $83.56 |
| 3008F | <1% | 237 | $8.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 51 | $1.98 |
| 99000 | 0% | 71 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATEL, PARTHSARTHI (MEDICAL DIRECTOR)